Cdk5 Sebagai Target Potensial Penemuan Obat Anti Nyeri Kronik

Authors

  • Mohammad Fathul Qorib Departemen Anatomi Histologi dan Farmakologi FK Unair, Surabaya, Indonesia
  • Abdul Khairul Rizki Purba Departemen Anatomi Histologi dan Farmakologi FK Unair, Surabaya, Indonesia
  • Annete d’Arqom Departemen Anatomi Histologi dan Farmakologi FK Unair, Surabaya, Indonesia

DOI:

https://doi.org/10.29303/jk.v12i3.4442

Keywords:

Chronic pain, Cdk5, Cdk5 inhibitor

Abstract

Chronic pain is a very disturbing condition and to date, no effective and safe medicine has been found. This could be caused by existing drugs not targeting the key factor in pain transmission. Cdk5 is a protein kinase that has been shown to have a key role in the transmission of chronic pain. These important roles include: activation of TRPV1, NMDA, P/Q type voltage-dependent calcium channels, and ATP-gate P2X receptors. Cdk5 could be used as a potential target in the development of new anti-chronic pain drugs. Several aspects of concern in developing this drugs are the role of Cdk5 in physiological and pathological conditions because it’s will be related to the risk of side effects. Another factor that really needs to be considered is the location of Cdk5 expression because it will related to the drug design. Several drugs that have been developed as Cdk5 inhibitors are roscovitin, olomoucine, and indirubin.  

Downloads

Published

2023-09-30

Issue

Vol. 12 No. 3 (2023): Jurnal Kedokteran

Section

Articles

License

Authors who publish with Unram Medical Journal, agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License (CC-BY License). This license allows authors to use all articles, data sets, graphics, and appendices in data mining applications, search engines, websites, blogs, and other platforms by providing an appropriate reference. The journal allows the author(s) to hold the copyright without restrictions and will retain publishing rights without restrictions.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in University of Mataram's Journal of Medicine. 
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
  4. This journal is open access journal which means that all content is freely available without charge to users or / institution. Users are allowed to read, download, copy, distribute, print, search, or link to full text articles in this journal without asking prior permission from the publisher or author.